000 02652nam a22001937a 4500
001 CUHAS/BP/3000114/T/13
008 210730b |||||||| |||| 00| 0 eng d
100 _a Mahuma, Sami. B
_dCUHAS/BP/3000114/T/13
_920095
_eUndergraduate Ethical Clearance Certificate No. 289/2017
245 _a Assessment of Physicochemical Quality of Commercially Available Albendazole Brands in Mwanza City.
260 _aMwanza, Tanzania:
_bCatholic University of Health and Allied Sciences [CUHAS - Bugando] :
_bPhone: +255 28 298 3384 :
_b Fax: +255 28 298 3386 :
_b Email: vc@bugando.ac.tz :
_bWebsite: www.bugando.ac.tz :
_c©10.08.2017
300 _a ix; 25 Pages
300 _aIncludes References and Appendices
520 _aAbstract: Introduction: The assessment of physical and chemical quality parameters of a pharmaceutical product using internationally recognized pharmacopoeia is crucial in assuring that only products of acceptable quality circulate in the market. The use of substandard and counterfeit medicinal products has been associated with treatment failure, development of disease causative agent resistance against the drug, adverse drug reactions and sometimes death. Therefore this study aimed to assess physical and chemical parameters of four Albendazole tablets brands as per United States Pharmacopeia (USP 38 NF 33) monographs. The investigated parameters include hardness, mass uniformity for physical and amount of active pharmaceutical ingredient (API), dissolution for chemical parameters. These assessed brands included Alben® (Shelys, Tanzania), Finazol® (Fourrts, India), Zentel® (GSK, South Africa) and Alzental® (Shin Poong, South Korea) which were collected from pharmacies in Mwanza city. Methods: All samples were prepared according to the standard operating procedures (SOPs) and necessary calculations were made. Then all procedures were done using specified equipment and material, data was then collected and analyzed. Results: Among the four parameters investigated, only two parameters (mass uniformity and amount of active pharmaceutical ingredient) complied with the USP specifications for all four brands while for the other two (hardness and dissolution) did not comply. Although only one brand. Zentel® complied with the dissolution test. Conclusion: Therefore the periodic monitoring programs of marketing authorized products are important to ensure the quality of circulating medicine in the market.
600 _xPharmacy
_926693
600 _xParasitology
_930263
700 _aRuganuza, Deodatus
_920068
700 _aKatabalo, Deogratius
_919841
942 _2ddc
_cCR
999 _c20296
_d20296